Cosmos Health Stock-Based Compensation Growth & History (COSM)
Cosmos Health's stock-based compensation was $2.3M for fiscal 2025.
View full Cosmos Health company overviewCosmos Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.3M | $622,529 | +36.84% |
| 2024 | 2024-12-31 | $1.7M | $1.1M | +192.37% |
| 2023 | 2023-12-31 | $577,931 | $553,530 | +2268.47% |
| 2022 | 2022-12-31 | $24,401 | −$5.9M | −99.59% |
| 2021 | 2021-12-31 | $5.9M | — | — |
| 2018 | 2018-12-31 | $242,002 | −$96,790 | −28.57% |
| 2017 | 2017-12-31 | $338,792 | $322,156 | +1936.50% |
| 2016 | 2016-12-31 | $16,636 | −$11,716 | −41.32% |
| 2015 | 2015-12-31 | $28,352 | — | — |
| 2013 · Jul 31 | 2013-07-31 | $70,200 | −$17,700 | −20.14% |
| 2012 · Jul 31 | 2012-07-31 | $87,900 | $24,700 | +39.08% |
| 2011 | 2011-07-31 | $63,200 | — | — |
Cosmos Health quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $558,858 | −$44,163 | −7.32% |
| Q1 2026 | 2026-03-31 | $535,786 | −$20,825 | −3.74% |
| Q4 2025 | 2025-12-31 | $582,008 | −$4,504 | −0.77% |
| Q3 2025 | 2025-09-30 | $570,601 | $147,790 | +34.95% |
| Q2 2025 | 2025-06-30 | $603,021 | $262,826 | +77.26% |
| Q1 2025 | 2025-03-31 | $556,611 | $216,417 | +63.62% |
| Q4 2024 | 2024-12-31 | $586,512 | $223,086 | +61.38% |
| Q3 2024 | 2024-09-30 | $422,811 | $313,175 | +285.65% |
| Q2 2024 | 2024-06-30 | $340,195 | $235,326 | +224.40% |
| Q1 2024 | 2024-03-31 | $340,194 | $340,194 | — |
| Q4 2023 | 2023-12-31 | $363,426 | — | — |
| Q3 2023 | 2023-09-30 | $109,636 | $106,516 | +3413.97% |
| Q2 2023 | 2023-06-30 | $104,869 | — | — |
| Q1 2023 | 2023-03-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $3,120 | — | — |
| Q4 2018 | 2018-12-31 | $60,998 | −$12,265 | −16.74% |
| Q3 2018 | 2018-09-30 | $60,998 | −$28,541 | −31.88% |
| Q2 2018 | 2018-06-30 | $60,335 | −$28,409 | −32.01% |
| Q1 2018 | 2018-03-31 | $59,671 | −$27,575 | −31.61% |
| Q4 2017 | 2017-12-31 | $73,263 | — | — |
| Q3 2017 | 2017-09-30 | $89,539 | — | — |
| Q2 2017 | 2017-06-30 | $88,744 | — | — |
| Q1 2017 | 2017-03-31 | $87,246 | — | — |
| Q3 2015 | 2015-09-30 | $0 | — | — |
| Q1 2013 · Apr 30 | 2013-04-30 | $0 | $0 | — |
| Q2 2013 · Jan 31 | 2013-01-31 | $43,151 | $15,251 | +54.66% |
| Q1 2013 · Oct 31 | 2012-10-31 | $70,200 | $10,200 | +17.00% |
| Q4 2012 | 2012-07-31 | $0 | $0 | — |
| Q3 2012 | 2012-04-30 | $0 | −$63,200 | — |
| Q2 2012 | 2012-01-31 | $27,900 | $27,900 | — |
| Q1 2012 | 2011-10-31 | $60,000 | $60,000 | — |
| Q4 2011 | 2011-07-31 | $0 | — | — |
| Q3 2011 | 2011-04-30 | $63,200 | — | — |
| Q2 2011 | 2011-01-31 | $0 | — | — |
| Q1 2011 | 2010-10-31 | $0 | — | — |
Cosmos Health stock-based compensation trends
Between the periods ended 2011-07-31 and 2025-12-31, Cosmos Health's stock-based compensation increased from $63,200 to $2.3M, a change of $2.2M. The latest reported quarter, Q2 2026, shows $558,858.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cosmos Health source filings ↗